AI Biomed PredictionsMRKR – Marker Therapeutics Poised for Breakout with Key Clinical Results Imminent ScanScor Admin / July 7, 2025
AI Biomed PredictionsNKTR – Promising Phase 2b Trials Propel Nektar’s Investment Potential ScanScor Admin / July 3, 2025